“Professional and friendly staff. Clean and very modern equipment. Would definitely recommend!”
Why a Retina Specialist Should Manage Your Eye Injections
Who Is a Retina Specialist
A Retina Specialist is an ophthalmologist who has completed additional years of advanced training devoted entirely to diseases of the retina and vitreous. This focused expertise sets them apart from general eye doctors in meaningful ways that directly affect patient outcomes.
After earning a medical degree, a Retina Specialist completes a three-year ophthalmology residency followed by a two-year vitreoretinal fellowship. The fellowship provides intensive, hands-on training in intravitreal injection technique, advanced retinal imaging, and vitreoretinal surgery. Many fellows perform hundreds of intravitreal injections during training alone before ever seeing patients independently.
General ophthalmologists are skilled physicians who diagnose and treat a wide variety of eye conditions, from cataracts to glaucoma. However, they do not have the same depth of focused training in retinal disease that a fellowship-trained Retina Specialist carries. Two additional years of subspecialty training make a meaningful difference when a condition requires ongoing, complex management.
Retina Specialists use advanced diagnostic tools such as optical coherence tomography (OCT), fluorescein angiography, and wide-field imaging. These tools reveal the subtle changes in the retina that determine whether a treatment is working and whether an adjustment is needed.
Board certification through the American Board of Ophthalmology confirms that a physician has met rigorous standards in training, knowledge, and patient safety. Research supports a meaningful connection between physician certification and lower rates of injection-related complications. Professional retinal societies consistently recommend that intravitreal injections be performed by fellowship-trained specialists using established protocols.
Why Specialist Expertise Matters at Every Injection Visit
The injection itself takes only a few seconds. What surrounds that moment, including diagnosis, medication selection, imaging interpretation, and ongoing monitoring, requires the depth of knowledge that a Retina Specialist develops through years of focused training.
A Retina Specialist does not simply administer an injection and send patients on their way. Before any injection is given, the specialist confirms the diagnosis, reviews imaging, evaluates whether the condition has changed, and determines whether the current medication and schedule are still appropriate. Each visit is a clinical decision, not a routine procedure.
A provider who performs injections without a full understanding of the underlying retinal disease may miss important changes that signal a need for a different approach.
Before and throughout injection therapy, Retina Specialists rely on specialized imaging to guide every treatment decision. OCT scanning produces detailed cross-sectional images of the retinal layers, revealing fluid, swelling, or tissue loss that cannot be seen during a standard eye exam.
Fluorescein angiography uses a special dye to map blood flow patterns in the retina, identifying abnormal vessel growth and areas of active leakage. Interpreting these images accurately, and knowing when findings require a change in treatment, is a skill built through years of subspecialty experience.
Not all retinal conditions respond to the same medication. A Retina Specialist chooses from several different injectable drugs based on the specific disease, the patient's treatment history, and how the eye has responded over time. Making this decision well requires a deep understanding of retinal pharmacology, not just the ability to perform an injection.
Most patients need repeated injections over an extended period. A Retina Specialist often uses a treat-and-extend approach, gradually increasing the time between injections as long as the condition remains stable. This approach aims to maintain vision benefit while reducing the total number of injections a patient needs.
Recognizing when a treatment is no longer working is equally important. A Retina Specialist monitors subtle changes on imaging that may indicate it is time to switch medications or adjust the treatment plan entirely.
Medications Used in Intravitreal Injections
Several different classes of medication can be delivered through intravitreal injection, each targeting a different aspect of retinal disease. A Retina Specialist selects the most appropriate option for each patient based on the condition being treated and individual response to therapy.
Anti-VEGF medications work by blocking vascular endothelial growth factor (VEGF), a protein responsible for abnormal blood vessel growth and fluid leakage in the retina. These are the most widely used intravitreal treatments and form the foundation of care for wet AMD, diabetic macular edema, and retinal vein occlusion.
- Eylea (aflibercept), one of the most commonly used anti-VEGF agents, typically given after an initial loading phase
- Lucentis (ranibizumab), the first anti-VEGF medication approved specifically for retinal use
- Vabysmo (faricimab), a bispecific antibody that targets two pathways and may allow longer intervals between injections
- Avastin (bevacizumab), FDA-approved for cancer and widely used off-label for retinal conditions
Each agent works in a slightly different way. A Retina Specialist understands these differences and selects the best option for each patient's specific situation.
Corticosteroid injections reduce inflammation and fluid buildup in the retina and are used for certain cases of diabetic macular edema, uveitis, and retinal vein occlusion. One example is a dexamethasone implant, a small device placed inside the eye that slowly releases medication over several months.
Corticosteroid injections carry a higher risk of certain complications, including elevated eye pressure and infection, compared to anti-VEGF medications. A Retina Specialist carefully weighs these risks before recommending this type of treatment.
Geographic atrophy is an advanced form of dry AMD in which retinal cells progressively break down, leading to central vision loss. Until recently, no approved treatments existed for this condition. Izervay (avacincaptad pegol) is now an FDA-approved complement inhibitor given by intravitreal injection to slow the progression of geographic atrophy in qualifying patients.
A Retina Specialist can evaluate whether a patient with advanced dry AMD is a candidate for this newer therapy and explain what outcomes are realistically expected.
Safety and What to Expect
Intravitreal injections are considered a safe procedure when performed by experienced specialists following proper protocols. Understanding what happens before, during, and after an injection helps patients feel more prepared and know when to seek urgent care.
The most serious complication of intravitreal injection is endophthalmitis, a severe infection inside the eye that requires immediate treatment. Retina Specialists follow strict infection prevention protocols at every injection visit. These include applying povidone-iodine antiseptic to the eye surface before the injection, using sterile instruments, and maintaining a no-talking policy during the procedure.
When performed by experienced, board-certified specialists using these protocols, the rate of endophthalmitis is very low, though it is not zero. The consequences of this complication can be severe if not treated promptly, which is why recognizing warning signs after an injection is essential.
At each injection visit, your Retina Specialist will examine your eye and typically perform imaging such as an OCT scan to assess the current state of your retina. This information guides the decision to inject and which medication to use. Numbing drops are applied, the eye is cleaned with antiseptic solution, and a small device may be used to gently hold the eyelids open during the procedure.
The injection itself takes only a few seconds. Most patients feel pressure or mild discomfort rather than sharp pain. After the injection, the specialist checks the eye, and you may notice mild floaters or temporary redness at the injection site. These effects typically resolve within a few days.
Because most retinal conditions require ongoing treatment, follow-up visits are a central part of your care. At each visit, your Retina Specialist evaluates how your eye is responding and determines the timing of the next injection. Staying consistent with your appointment schedule is one of the most important things you can do to protect your vision.
When to Seek Immediate Care
Most patients tolerate intravitreal injections well with only minor temporary side effects. However, certain symptoms after an injection are warning signs that require urgent evaluation and should never be ignored or waited out at home.
Contact a Retina Specialist or go to an emergency room right away if you experience any of the following after an intravitreal injection.
- Severe eye pain or pain that worsens over the days following the injection
- A significant decrease in vision from your usual baseline
- A sudden large increase in floaters or flashing lights
- A dark curtain or shadow appearing in any part of your vision
- Excessive redness, swelling, or discharge from the eye
- Fever occurring alongside any eye symptoms
These symptoms may indicate endophthalmitis, retinal detachment, or vitreous hemorrhage. Each of these conditions can cause permanent vision loss if treatment is delayed. Do not wait to see if symptoms improve on their own.
If you have been receiving intravitreal injections and your vision is not responding as expected, or if it appears to be worsening, speak with your Retina Specialist at your next visit. A thorough review of your imaging and treatment history may reveal that a medication change or adjusted schedule is needed. Patients who are not yet seeing a Retina Specialist should ask their referring doctor about a formal referral for this type of evaluation.
Frequently Asked Questions
These questions address common points of confusion about intravitreal injections, provider qualifications, and what to do in specific situations.
No. Intravitreal injections require the medical training and licensure of an ophthalmologist. Optometrists play a valuable role in eye care by detecting retinal conditions early and providing referrals, but performing injections falls outside their scope of practice. If an optometrist identifies a condition that may need injection therapy, the appropriate next step is a referral to a fellowship-trained Retina Specialist for evaluation and treatment.
You can ask your provider directly about their training. A fellowship-trained Retina Specialist will have completed a two-year vitreoretinal surgery fellowship after finishing an ophthalmology residency. You can also verify credentials through the American Board of Ophthalmology. Choosing a single-specialty retinal practice, rather than a general ophthalmology group, is one of the most reliable ways to confirm you are seeing a true subspecialist.
Gaps in treatment can allow the underlying retinal condition to become active again. Fluid may return, abnormal blood vessels may regrow, or inflammation may increase. In some cases, the vision lost during a gap in treatment may not be fully recoverable once injections resume. If scheduling conflicts arise, contact your Retina Specialist's office as soon as possible so that your appointment can be rescheduled with the shortest possible delay.
In some situations, a Retina Specialist may recommend treating both eyes at the same visit, but this decision is made carefully. Same-day bilateral injections carry a small added risk, including the rare possibility of infection in both eyes simultaneously. Your Retina Specialist will weigh the potential benefit of convenience against these considerations and discuss the approach that is safest for your specific situation.
Most major insurance plans, including Medicare, cover intravitreal injections when they are medically necessary and performed by a qualified specialist. Coverage details vary by plan and by the specific medication used. Because anti-VEGF agents differ in cost and approval status, the choice of medication can affect your out-of-pocket expense. Your Retina Specialist's office can help clarify coverage and navigate prior authorization requirements when needed.
Schedule Your Evaluation at Atlantic Retina Center
Our team of fellowship-trained, ABO board-certified Retina Specialists is dedicated exclusively to retinal care, bringing focused expertise to every injection visit, every imaging review, and every treatment decision. We understand that managing a retinal condition over time requires more than a routine procedure, and we are committed to providing the careful, continuous care your vision deserves. If you are on the Eastern Shore of Maryland or in central and southern Delaware and have been referred for injection therapy or have concerns about your retinal health, we welcome you to reach out and schedule a consultation with our team.